New Zealand Doctor | New Zealand Doctor
Cameron Schauer and Jason Robertson describe the symptoms, aetiology, subtypes and consequences of reflux. They also discuss the investigations used for diagnosis, investigating those with alarm features and evaluating success of treatment. Finally, they examine multimodal treatment, including lifestyle, pharmacological and surgical interventions.
Heart Foundation welcomes news of funded treatment for heart …
1 day ago · The Heart Foundation's call for wider access to a heart medication has been successful, with Pharmac announcing today that it will fund a drug used in the treatment of chronic heart failure, a move that will benefit more than 18,000 New Zealanders over the next 12 months. The drug (empagliflozin) will be available to people who have chronic ...
+All News | New Zealand Doctor
1 day ago · New Zealand Health Plan won’t be signed off until 2025 due to delays. The New Zealand Health Plan Te Pae Waenga is now not expected to be signed off by the health minister until next year, according to Te Whatu Ora director of planning and outcomes Lisa Williams. Read more. By Stephen Forbes. Monday 11 November 2024, 04:24 PM. 3 minutes to Read.
New diabetes data confirms ‘worst case’ predictions
2 days ago · The Economic and Social Cost of Type 2 Diabetes report released in 2021 predicted that by 2040 there would be up to 430,000 people living with type 2 diabetes in Aotearoa. The new data shows the figures are tracking well above this prediction. “We can’t sugar coat the size of the problem,” says Heather Verry, chief executive of Diabetes ...
Loneliness and isolation among older Kiwis at epidemic levels
2 days ago · 4 minutes to Read. The impact of loneliness and social isolation on the health outcomes of older New Zealanders has reached epidemic levels, according to a new study. The research findings have led health advocates to call for the government to establish a Ministerial lead for Loneliness, similar to that found in the United Kingdom and Japan.
Newly funded medicine to benefit 110 more people with thyroid, …
5 days ago · Pharmac has decided to fund lenvatinib from 1 December 2024 for people with some types of thyroid, liver, and kidney cancer. Lenvatinib (branded as Lenvima) stops the number of cancer cells from increasing, slowing the cancer’s progression. The medicine is taken as oral capsule that people can ...
Older Kiwis urged to get COVID-19 boosters | New Zealand Doctor
Dec 13, 2023 · As Kiwis prepare for Christmas, public health officials are recommending that people who are more likely to experience severe COVID-19, such as Māori and Pacific people aged 50 and over, as well as everyone aged 65 and older, get a booster vaccine before the holidays. Dr Nicholas Jones Director of Public Health says New Zealand has been ...
Thousands of Kiwis Set to Access Newly Funded ... - New Zealand …
Mar 1, 2023 · [1] Strezova A et al. Long-term protection against herpes zoster (HZ) by the adjuvanted recombinant zoster vaccine (RZV): interim efficacy, immune and safety results at approximately 10 years after initial vaccination. Open Forum Infectious Diseases. 2022 [2] Immunisation Advisory Centre. Shingrix. Accessible here. …
New booster plan in time for winter | New Zealand Doctor
Feb 23, 2023 · New booster plan in time for winter. All New Zealanders aged 30 and over will be able to access the new COVID bivalent booster from April as part of the Government’s plan to keep Kiwis safe and take pressure off our health system, says Minister of Health Dr Ayesha Verrall. The new bivalent vaccine will replace the existing Pfizer booster and ...
Navigating COVID-19 antiviral access criteria - New Zealand Doctor
Chris Ellis. Wednesday 20 July 2022, 12:20 AM. ECG supplied. Consultant cardiologist Chris Ellis looks at the COVID-19 antiviral treatments available for use in New Zealand, including the current access criteria set by Pharmac. Late news, As we went to press, Pharmac announced that, effective from 18 July, the COVID-19 antiviral access criteria ...